NAD+, Sirtuins & Hormonal Aging

Introduction: The Aging-Hormone Connection

Hormonal decline is one of the most visible and consequential features of biological aging. Testosterone, estrogen, progesterone, DHEA, growth hormone, and thyroid hormones all follow a downward trajectory with age — a process that accelerates chronic disease, cognitive decline, metabolic dysfunction, and loss of vitality. But what drives this hormonal aging at the cellular level?

Increasingly, the answer points to NAD+ (nicotinamide adenine dinucleotide) — a coenzyme found in every cell of the body that serves as the master regulator of cellular energy, DNA repair, and longevity signaling. NAD+ decline with age is not merely a consequence of aging; it is a driver of it — including the hormonal dysregulation that defines the aging phenotype.

What Is NAD+?

NAD+ is a dinucleotide coenzyme derived from niacin (vitamin B3) that exists in two interconvertible forms: NAD+ (oxidized) and NADH (reduced). It functions as an essential electron carrier in cellular metabolism — shuttling electrons through the mitochondrial electron transport chain to generate ATP. But beyond energy metabolism, NAD+ serves as a critical substrate for:

• Sirtuins (SIRT1–7): NAD+-dependent deacetylases that regulate gene expression, DNA repair, inflammation, and metabolic homeostasis.
• PARPs (Poly ADP-ribose polymerases): DNA damage repair enzymes that consume NAD+ to detect and repair DNA strand breaks.
• CD38: An NAD+-consuming enzyme involved in immune signaling and calcium homeostasis; CD38 activity increases with age and inflammation, accelerating NAD+ depletion.

NAD+ Decline with Age

NAD+ levels decline by approximately 50% between the ages of 40 and 60, with further decline thereafter. This decline is driven by:

• Increased PARP activation: Accumulating DNA damage with age drives PARP activity, consuming NAD+ at an accelerating rate.
• CD38 upregulation: Chronic inflammation (inflammaging) upregulates CD38, a major NAD+ consumer.
• Reduced biosynthesis: The salvage pathway — the primary route of NAD+ recycling — becomes less efficient with age due to declining NAMPT (nicotinamide phosphoribosyltransferase) activity.
• Mitochondrial dysfunction: Impaired mitochondria produce less NAD+ and consume it less efficiently.

The consequences of NAD+ decline are systemic: impaired mitochondrial function, reduced DNA repair capacity, increased inflammation, metabolic dysfunction, and — critically — hormonal dysregulation.

Sirtuins: The Longevity Enzymes

Sirtuins are a family of seven NAD+-dependent protein deacetylases (SIRT1–7) that regulate virtually every hallmark of aging. They require NAD+ as a co-substrate — meaning their activity is directly limited by NAD+ availability. As NAD+ declines, sirtuin activity falls, accelerating the aging process.

Key Sirtuin Functions

• SIRT1: Master metabolic regulator; activates PGC-1α (mitochondrial biogenesis), regulates insulin sensitivity, modulates inflammatory NF-κB signaling, and controls circadian clock genes.
• SIRT2: Regulates cell cycle, microtubule stability, and metabolic homeostasis.
• SIRT3: Mitochondrial sirtuin; activates antioxidant defenses (SOD2), regulates fatty acid oxidation, and protects against oxidative stress.
• SIRT4: Regulates amino acid metabolism and insulin secretion in pancreatic beta cells.
• SIRT5: Regulates urea cycle and mitochondrial metabolism.
• SIRT6: DNA repair, telomere maintenance, and suppression of inflammatory gene expression; SIRT6 overexpression extends lifespan in animal models.
• SIRT7: Regulates ribosomal RNA synthesis and stress responses.

Sirtuins and Hormonal Regulation

The connection between sirtuins and hormonal health is direct and multidirectional:

• SIRT1 and steroidogenesis: SIRT1 regulates the expression of steroidogenic enzymes in the adrenal glands and gonads. SIRT1 deficiency impairs cortisol, DHEA, testosterone, and estrogen synthesis.
• SIRT1 and the HPG axis: SIRT1 modulates GnRH neuron activity and LH pulsatility — declining SIRT1 activity with age contributes to reduced gonadotropin signaling and sex hormone decline.
• SIRT1 and thyroid function: SIRT1 regulates thyroid hormone receptor sensitivity and deiodinase activity, affecting T3 availability at the cellular level.
• SIRT3 and adrenal function: Mitochondrial SIRT3 is essential for adrenal steroidogenesis; SIRT3 deficiency impairs cortisol and DHEA production under stress.
• SIRT6 and IGF-1 signaling: SIRT6 suppresses IGF-1 signaling in a context-dependent manner, modulating the growth hormone-IGF-1 axis and its effects on longevity.

NAD+ and Hormonal Aging: Key Mechanisms

DHEA and Adrenal NAD+ Dependence

DHEA — the most abundant circulating steroid hormone and a precursor to both testosterone and estrogen — declines by over 80% between ages 25 and 75. Adrenal DHEA synthesis is mitochondria-dependent and NAD+-sensitive. Restoring NAD+ levels supports adrenal mitochondrial function and may partially restore DHEA production capacity.

Testosterone and NAD+

Leydig cell testosterone synthesis is an energy-intensive, mitochondria-dependent process. NAD+ decline impairs Leydig cell mitochondrial function, reducing testosterone biosynthetic capacity. Animal studies show NAD+ precursor supplementation can restore testosterone levels in aged males.

Estrogen Metabolism and SIRT1

SIRT1 regulates estrogen receptor alpha (ERα) activity through deacetylation, modulating estrogen signaling sensitivity. SIRT1 also influences the expression of CYP enzymes involved in estrogen metabolism, affecting the balance between protective and proliferative estrogen metabolites.

Growth Hormone and NAD+

GH secretion is pulsatile and sleep-dependent. NAD+ decline impairs circadian clock function (SIRT1 is a core clock regulator), disrupting the sleep architecture that drives GH release. Restoring NAD+ may improve sleep quality and GH pulsatility.

Insulin Sensitivity and the NAD+-Sirtuin Axis

SIRT1 and SIRT3 are central regulators of insulin sensitivity. SIRT1 activates PGC-1α, improving mitochondrial function and glucose metabolism. SIRT3 reduces mitochondrial reactive oxygen species, protecting insulin signaling pathways. NAD+ decline → reduced sirtuin activity → impaired insulin sensitivity → elevated insulin → hormonal disruption (PCOS, testosterone suppression, estrogen dominance).

NAD+ Precursors: NMN vs. NR vs. Niacin

Three primary NAD+ precursors are used clinically to restore NAD+ levels:

Both NMN and NR have demonstrated the ability to raise blood and tissue NAD+ levels in human clinical trials. NMN has shown particular promise in studies on muscle NAD+ restoration and insulin sensitivity in older adults.

Resveratrol and Sirtuin Activation

Resveratrol — a polyphenol found in red wine and grape skins — was identified as a SIRT1 activator in landmark research by David Sinclair’s laboratory. While the direct SIRT1 activation mechanism has been debated, resveratrol’s effects on mitochondrial biogenesis, inflammation, and metabolic function are well-documented. It is frequently combined with NMN or NR in longevity protocols to amplify sirtuin signaling.

Lifestyle Interventions That Raise NAD+

Beyond supplementation, several lifestyle interventions robustly raise NAD+ levels:

• Caloric restriction and intermittent fasting: Activate AMPK and SIRT1, upregulate NAMPT, and reduce CD38 activity.
• Exercise: Particularly high-intensity interval training (HIIT) raises NAD+ in muscle tissue and activates SIRT1 and SIRT3.
• Heat exposure (sauna): Activates heat shock proteins and mitochondrial biogenesis pathways that support NAD+ metabolism.
• Cold exposure: Activates brown adipose tissue and mitochondrial uncoupling, increasing NAD+ demand and production.
• Sleep optimization: SIRT1 is a core circadian clock regulator; consistent sleep timing supports NAD+ cycling.

Integrative Protocol for NAD+ and Hormonal Aging

A comprehensive NAD+-focused hormonal aging protocol includes:

• NAD+ precursor: NMN 500–1000 mg/day or NR 300–500 mg/day (morning, with or without food)
• Sirtuin activators: Resveratrol 500 mg/day (with fat for absorption), quercetin, fisetin
• CD38 inhibition: Apigenin (found in parsley, chamomile) inhibits CD38 and reduces NAD+ consumption
• Mitochondrial support: CoQ10/Ubiquinol, PQQ, alpha-lipoic acid, magnesium
• Hormonal optimization: Address DHEA, testosterone, estrogen, thyroid, and GH as indicated by testing
• Lifestyle foundation: Intermittent fasting, HIIT, sauna, sleep optimization

Key Takeaways

• NAD+ declines by ∼50% between ages 40–60, driving mitochondrial dysfunction, impaired DNA repair, and hormonal aging.
• Sirtuins (SIRT1–7) are NAD+-dependent longevity enzymes that directly regulate steroidogenesis, HPG axis function, thyroid sensitivity, and insulin signaling.
• NAD+ decline contributes to reduced DHEA, testosterone, estrogen metabolism efficiency, GH pulsatility, and insulin sensitivity.
• NMN and NR are the most clinically studied NAD+ precursors; both reliably raise blood NAD+ levels in humans.
• Lifestyle interventions — fasting, HIIT, sauna, sleep — are foundational NAD+ restoration strategies that amplify the effects of supplementation.
• A comprehensive hormonal aging protocol integrates NAD+ restoration with targeted hormonal optimization and root-cause lifestyle medicine.